The in vivo antiatherogenic activity of two calcium antagonists of the dihydropyridine class (isradipine and lacidipine) was investigated in a new experimental model. The proliferative lesion induced in the rabbit carotid artery was obtained by positioning a hollow silastic collar around the vessel. The neointimal formation was determined by measuring cross sectional thickness of intimal (I) and medial (M) tissue of fixed arteries obtained 14 days after collar placement. The effectiveness in inhibiting neointimal formation was assessed for isradipine (0·5, 1 and 4 mg kg −1 day −1 ) in normocholesterolemic (NC) animals and for lacidipine (1, 3, and 10 mg kg −1 day −1 ) in hypercholesterolemic (HC) rabbits. In NC control animals a neointimal formation was clearly detectable (I/M 0·53±0·18, n=5). In isradipine-treated groups I/M ratios were significantly decreased (0·15±0·03, 0·12±0·02, 0·1±0·02 for the 0·5, 1 and 4 mg kg −1 day −1 doses respectively). In HC rabbits the administration of cholesterol 1% mixed with food and drug treatment started either 60 days before collar insertion (pretreated group, HC60) or on the same day (non pretreated group, HC15) of the collar placement. Only the pharmacological pretreatment was effective in reducing neointimal formation (0·47±0·02, 0·4 ±0·09, and 0·32±0·02 for dose 1, 3 and 10 mg kg −1 day −1 vs 1·1±0·14 in control animals). The inhibition of neointimal hyperplasia was much less evident in nonpretreated animals (0·7± 0·15, 0·6±0·18 and 0·43±0·08 for dose 1, 3, and 10 mg kg −1 day −1 vs 0·72±0·2 in control animals). These results suggest a direct antiatherosclerotic effect of isradipine and lacidipine on neointimal hyperplasia induced in NC and HC pretreated rabbits independently of modulation of risk factors such as hypercholesterolemia and/or hypertension.
INTRODUCTION
(SMC) migration from the media and proliferation within the intima, and increase lipid deposition or With the increasing knowledge on the pathogenesis of reduce lipid clearance from infiltrating monocytes. These processes trigger a cascade of events leading to atherosclerosis it appears that prevention of cardiovascular disease will involve not only the correction of the development of vascular disease [1] [2] [3] . risk factors such as dyslipidemia or elevated arterial blood pressure but also the direct pharmacological Therapeutic interventions which interfere with early stages of atherosclerosis may improve the control of atherogenic processes occurring in the arterial wall [1] . While the former approach is now chances of halting and slowing the disease progression. Among drugs currently available for therapy definitely accepted in man, the latter still represents a 'therapeutic hope' which requires experimental and of vascular disease calcium antagonists have been investigated extensively as antiatherogenic agents in a clinical confirmation. Recently, a great effort has been made in evaluating the direct effect of drug therapy on variety of in vitro and in vivo experimental models [2, [4] [5] [6] [7] . Increases in intracellular calcium are a very the arterial wall [2] . Abnormalities or dysfunctions of the vessel wall can favor vascular smooth muscle cell basic biological signaling mechanism involving numerous processes, such as platelet activation, SMC migration and proliferation, and endothelial dysfunc- endothelial injury, and experimental calcinosis [8] [9] [10] [11] [12] [13] . The in vitro effects of these drugs on pro-cesses which play a role in the development of athero-
Neointimal hyperplasia induction and evaluation
Intimal hyperplasia was mechanically induced in sclerotic lesions might help in explaining these results. For instance, several calcium antagonists one carotid artery, after the anesthesia of rabbits by intramuscular injection of 5 mg kg −1 xylazine and inhibit SMC migration [14] , the uptake of lipids by macrophages [15] [16] [17] [18] . However, few attempts have 35 mg kg −1 ketamine. Animals were then placed in dorsal recumbency. A neck midline incision was made been made to relate these in vitro effects to the complex changes which occur in the vessel wall. Recently, and both carotid arteries were surgically exposed. A non occlusive, biologically inert, soft, and hollow Sila model of carotid neointimal hyperplasia, mainly dependent on SMC migration and proliferation, has astic R collar was positioned around both carotids. The collar was 1·5 cm in length and it touched the artery been developed [19, 20] . Using this model we investigated the in vivo effect of two dihydropiridines, isradcircumference at two points 1 cm apart. In the sham arteries the collar was removed just before carotids ipine and lacidipine, on a vascular lesion mainly characterized by migration and proliferation of SMC were repositioned and the wounds were sutured. Animals were killed 2 weeks after the collar placement. induced by collar insertion around a carotid artery of NC and HC animals.
All animals were given a lethal dose of sodium pentobarbital (65 mg kg 
Study protocol
New Zealand male rabbits (n=60) (2-2·5 kg, carotid arteries were retrieved, paraffin embedded and stained with hematoxylin/eosin. At least 600 cross Charles River, Calco, Italy) were used in this study. Animals were divided into the following groups and sections (5 µm) were cut for each artery. Neointimal formation was measured by light microscopy and maintained in identical experimental conditions. expressed as the ratio between the cross-sectional Normocholesterolemic animals.
thickness of intimal and medial tissue. Intimal/Medial Control group (n=5).
(I/M) ratios were calculated to normalize the data. The Low dose isradipine (n=5): isradipine 0·5 mg kg
value of I/M obtained from each animal is the mean of day −1 . at least 1000 measurements performed on at least 10 Intermediate dose isradipine (n=5): isradipine.
sections [19, 20] .
High dose isradipine (n=5): isradipine 4 mg kg In both NC and HC animals the daily doses of the drugs were given in the morning (at 08:00 h) each RESULTS mixed in 20 g of food pellets. Normal chow, up to 150 g, was added after all medicated diet was eaten There were no significant differences in the baseline (usually within 30 minutes). For HC animals 1% cholbody weight among groups of animals examined. esterol-rich diet was administered daily. In some rabBlood pressure values didn't change in all animals bits HC diet and lacidipine-treatment started 8 weeks under treatment. Serum cholesterol values increased before the surgical insertion of the collar (n=5 for with cholesterol feeding in hypercholesterolemic rabeach dose) (HC60), while other animals (n=5 for each bits in a time-dependent manner with a similar trend dose) received cholesterol and lacidipine from the in all animals (data not shown). same day of the collar positioning (HC15). Records of food intake did not show any significant difference among the groups or within the groups. The doses
Normocholesterolemic animals
The effectiveness of the periarterial insertion of the here utilized did not affect arterial blood pressure. Animals had free access to water and were kept in a collar in inducing intimal carotid thickening was firstly assessed in control animals. A marked increase 12 h light-dark cycle. Total serum cholesterol was measured by a standard enzymatic procedure.
in intimal thickness was evident in the carotids with intimal thickening [Fig. 1(B) ]. In all drug-treated animals a reduction of neointimal thickening, detectable as fewer intimal cell layers, was evident. Figure 1 (C) reports a typical transverse section obtained from isradipine-treated animals (intermediate dose). Isradipine at all concentrations significantly reduced the I/M ratio when compared with the positive-control-group of NC animals (0·14±0·03, 0·12±0·02, 0·1±0·02 for the 0·5, 1 and 4 mg kg −1 day −1 doses respectively). This effect is summarized in Fig. 2 .
Hypercholesterolemic animals collar [ Fig. 1(A) ], whereas the sham-operated arteries did not show thickening of the intima either in posiNeointimal formation in hypercholesterolemic rabbits was greater than that observed in normocholestertive control or drug-treated rabbits [ Fig. 1(B) ]. The mean value of the I/M ratio in the collar arteries of the olemic animals [19, 20] , suggesting a detrimental effect of hypercholesterolemia on this type of lesion. control group (n=5) was almost twenty-fold greater (0·53±0·18) than in the sham group (n=20) (0·03± In control rabbits I/M ratio was 1·1±0·14 and 0·71± 0·15 after 8 weeks and 2 weeks of cholesterol feeding, 0·02). The intimal thickening, covered by the endothelial monolayer, was mostly cellular even in the respectively. In this neointimal hyperplasia, mostly cellular, lipid depositions were also present [ 
3(B)]. Starting the treatment on the same day of the
In the present investigation we quantitated the influence of two calcium antagonists of the dihydropiridine collar placement, the inhibition of neointimal hyperplasia was much less evident (0·7±0·15, 0·6±0·18, and class (isradipine and lacidipine) on the development of an atherosclerotic lesion characterized mainly by whether dihydropyridine calcium antagonists could affect the development of this type of atherosclerotic smooth muscle cell accumulation. Administration of isradipine in NC animals resulted in a marked inhilesion. Both isradipine and lacidipine, effectively reduced the extent of neointimal hyperplasia induced bition of these lesions, with a dose-dependent inhibitory effect on neointimal hyperplasia. These findings in these animals, independently of blood pressure variations. At doses as low as 1 mg kg −1 day −1 both are consistent with the view that this dihydropyridine inhibits in vivo migration/proliferation of smooth drugs inhibited neointimal formation by about 50%. The lack of inhibition of I/M ratio in non pretreated muscle cells. Similar results were obtained in HC animals only with preventive treatment with lacidipine.
lacidipine HC animals suggests that lacidipine should be present at the site of the lesion before its surgical The increasing knowledge on the pathogenesis of atherosclerosis has prompted investigations into the induction since drug preferentially interferes with early atherogenic processes. possibility of direct pharmacological control of the pathological processes occurring in the arterial wall.
Results on this proliferative lesion strongly support the in vitro observation that lacidipine can affect Calcium antagonists are well established in the treatment of a number of cardiovascular disorders [21, 22] .
directly SMC migration and/or proliferation, a property shared with other calcium antagonists [27, 28] . Besides evidence that they reduce blood pressure, experimental and clinical data support the concept Lesion cellularity could be, on the other hand, modulated by enhanced programmed cell death (apoptosis), that Ca 2+ antagonists may protect against structural changes occurring in the vessel wall during the proa phenomenon particularly evident at early stages in this model (1-3 days after collar positioning, data not gression of atherosclerosis [2, [23] [24] [25] . Several calcium-dependent processes contribute to atherogenesis, shown). This issue is currently under investigation. Another possibility could be represented by the blockincluding lipid infiltration and oxidation, endothelial injury, chemotaxis and growth factor release, smooth ade of Ca 2+ -dependent processes related to the massive leukocyte infiltration observed at early stages in muscle cell migration and proliferation [21] .
Calcium antagonists modulate LDL cholesterol this model (data not published). This possible indirect inhibition of smooth muscle cell metabolism [26] and affect SMC migration and proliferation in vitro [2, 14, 27] . However, evidence is migration/proliferation should be investigated considering the effect of lacidipine in pretreated animals growing on the direct effect of calcium antagonists on intimal hyperplasia due to SMC migration and prokilled sooner (1, 3, 7 days) after collar placement.
In conclusion, the present in vivo findings show liferation [2, 13] . In this study we aimed at addressing 
